Goor, M.P.J. van

stroke ischemic stroke patient ischemic level study polymorphism control factor fibrinogen prothrombin blood risk factor protein mutation risk factors disease coagulation disorders coagulation association sample genotype pz levels odds ratio result disorder quartile variant prothrombin gene variant thrombosis chapter factor v leiden venous thrombosis fibrinogen levels ratio population plasma fvl mutation phase venou thromb allele group case-control difference tafi antigen levels inhibitor case-control study table infarction fibrinolysi tafi levels pz level event activity blood samples cause protein z levels leiden vessel disease history antigen plasminogen activator inhibitor occurrence convalescent phase interval month method hypertension smoking presence diabetes tobramycin platelet relationship 20210a promoter plasminogen figure case-control studies